Available literature suggests that anti-VEGF therapy is safe and efficacious for PED and nAMD. Treatment should focus on vision gains rather than PED resolution because there is no apparent correlation between anatomical and functional improvement in most eyes with PED and nAMD.
No takes yet. Share an insight, caveat, or question.
Khanani et al. (2018) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: